Fund manager's comment/Steven Laidlaw
At the beginning of June, there were grounds for thinking economic recovery was on its way. Interest rates were coming down around the world and, in such a situation, the appropriate strategy is to reduce defensive sectors like pharmaceuticals, which, in any case, appeared to be fully valued, and concentrate on cyclical sectors that can be expected to benefit when the economy picks up. However, during June, UK economic sentiment appeared to take a turn for the worse after some pessimistic market data. Inflation was higher than expected and employment figures were disappointing. This was a...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes